Skip to main content

Advertisement

Log in

Inhibitors of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase (Statins) Suppress Proliferation and Motility of Human CD4+ T Lymphocytes in Culture

  • BIOPHYSICS AND BIOCHEMISTRY
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) along with their blood lipid-lowering effect exhibit anti-inflammatory and immunomodulatory activity. We studied the effects of long-term (72-h or longer) exposure of human T lymphocytes in culture to atorvastatin and rosuvastatin (5-80 nM) on their functional activity. Treatment with statins inhibited PHA/IL-2-induced proliferation of CD4+ T lymphocytes isolated from the peripheral blood of healthy donors. This was accompanied by a decrease in the relative content of cells expressing active caspase-3. Addition of mevalonate or fetal bovine serum simultaneously with statins restored proliferative activity of cells. Culturing of CD4+ T lymphocytes with statins in the presence of IL-2 did not significantly affect the expression of chemokine receptors CCR4, CCR5, CXCR3, and CXCR4. Pretreatment with statins suppressed spontaneous and SDF-1-stimulated migration of CD4+ T lymphocytes, but little changed the content of intracellular phosphorylated protein kinases Akt, p38 and p42/44 (ERK1/2). The cellular effects of “lipophilic” atorvastatin were observed at lower concentrations compared to “hydrophilic” rosuvastatin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Filatova AYu, Potekhina AV, Ruleva NYu, Radyukhina NV, Arefieva TI. The influence of atorvastatin and rosuvastatin in atherosclerosis on the parameters of cellular immunity and in vitro leucocyte activation. Ross. Kardiol. Zh. 2018;23(8):59- 64. doi: https://doi.org/10.15829/1560-4071-2018-8-59-64. Russian.

  2. Arefieva TI, Filatova AY, Potekhina AV, Shchinova AM. Immunotropic effects and proposed mechanism of action for 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins). Biochemistry (Mosc). 2018;83(8):874-889. doi: https://doi.org/10.1134/S0006297918080023

    Article  CAS  PubMed  Google Scholar 

  3. Bennaceur K, Atwill M, Al Zhrany N, Hoffmann J, Keavney B, Breault D, Richardson G, von Zglinicki T, Saretzki G, Spyridopoulos I. Atorvastatin induces T cell proliferation by a telomerase reverse transcriptase (TERT) mediated mechanism. Atherosclerosis. 2014;236(2):312-320. doi: https://doi.org/10.1016/j.atherosclerosis.2014.07.020

    Article  CAS  PubMed  Google Scholar 

  4. Cai A, Zhou Y, Li L. Rho-GTPase and atherosclerosis: pleiotropic effects of statins. J. Am. Heart Assoc. 2015;4(7):e002113. doi: https://doi.org/10.1161/JAHA.115.002113

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Fong CW. Statins in therapy: understanding their hydrophilicity, lipophilicity, binding to 3-hydroxy-3-methylglutary- CoA reductase, ability to cross the blood brain barrier and metabolic stability based on electrostatic molecular orbital studies. Eur. J. Med. Chem. 2014;85:661-674. doi: https://doi.org/10.1016/j.ejmech.2014.08.037

    Article  CAS  PubMed  Google Scholar 

  6. Jameel A, Ooi KG, Jeffs NR, Galatowicz G, Lightman SL, Calder VL. Statin modulation of human T-cell proliferation, IL-1β and IL-17 production, and IFN-γ T cell expression: synergy with conventional immunosuppressive agents. Int. J. Inflam. 2013;2013:434586. doi: https://doi.org/10.1155/2013/434586

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Li D, Li Y, Hernandez JA, Patenia R, Kim TK, Khalili J, Dougherty MC, Hanley PJ, Bollard CM, Komanduri KV, Hwu P, Champlin RE, Radvanyi LG, Molldrem JJ, Ma Q. Lovastatin inhibits T-cell proliferation while preserving the cytolytic function of EBV, CMV, and MART-1-specific CTLs. J. Immunother. 2010;33(9):975-982. doi: https://doi.org/10.1097/CJI.0b013e3181fb0486

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Mausner-Fainberg K, Luboshits G, Mor A, Maysel-Auslender S, Rubinstein A, Keren G, George J. The effect of HMGCoA reductase inhibitors on naturally occurring CD4+CD25+ T cells. Atherosclerosis. 2008;197(2):829-839. doi: https://doi.org/10.1016/j.atherosclerosis.2007.07.031

    Article  CAS  PubMed  Google Scholar 

  9. Rodríguez-Perea AL, Montoya CJ, Olek S, Chougnet CA, Velilla PA. Statins increase the frequency of circulating CD4+ FOXP3+ regulatory T cells in healthy individuals. J. Immunol. Res. 2015;2015:762506. doi: https://doi.org/10.1155/2015/762506

    Article  PubMed  PubMed Central  Google Scholar 

  10. Ruleva NY, Radyukhina NV, Zubkova ES, Filatova AY, Aref’eva TI. Inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase (statins) suppress differentiation and reduce LPS/IFNγ-induced cytokine production in human monocyte/ macrophage culture. Bull. Exp. Biol. Med. 2020;170(2):236- 240. doi: https://doi.org/10.1007/s10517-020-05042-x

    Article  CAS  PubMed  Google Scholar 

  11. Tang TT, Song Y, Ding YJ, Liao YH, Yu X, Du R, Xiao H, Yuan J, Zhou ZH, Liao MY, Yao R, Jevallee H, Shi GP, Cheng X. Atorvastatin upregulates regulatory T cells and reduces clinical disease activity in patients with rheumatoid arthritis. J. Lipid Res. 2011;52(5):1023-1032. doi: https://doi.org/10.1194/jlr.M010876

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Vicente-Manzanares M, Cabrero JR, Rey M, Pérez-Martínez M, Ursa A, Itoh K, Sánchez-Madrid F. A role for the Rhop160 Rho coiled-coil kinase axis in the chemokine stromal cell-derived factor-1alpha-induced lymphocyte actomyosin and microtubular organization and chemotaxis. J. Immunol. 2002;168(1):400-410. doi: https://doi.org/10.4049/jimmunol.168.1.400

    Article  CAS  PubMed  Google Scholar 

  13. Waiczies S, Bendix I, Prozorovski T, Ratner M, Nazarenko I, Pfueller C. F, Brandt A. U, Herz J, Brocke S, Ullrich O, Zipp F. Geranylgeranylation but not GTP loading determines rho migratory function in T cells. J. Immunol. 2007;179(9):6024- 6032. doi: https://doi.org/10.4049/jimmunol.179.9.6024

  14. Zhang D, Wang S, Guan Y, Wang L, Xie W, Li N, Zhao P, Su G. Effect of oral atorvastatin on CD4+CD25+ regulatory T cells, FoxP3expression, and prognosis in patients with STsegment elevated myocardial infarction before primary percutaneous coronary intervention. J. Cardiovasc. Pharmacol. 2011;57(5):536-541. doi: https://doi.org/10.1097/FJC.0b013e318211d016

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N. V. Radyukhina.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 172, No. 8, pp. 162-167, August, 2021

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Radyukhina, N.V., Ruleva, N.Y., Filatova, A.Y. et al. Inhibitors of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase (Statins) Suppress Proliferation and Motility of Human CD4+ T Lymphocytes in Culture. Bull Exp Biol Med 172, 137–142 (2021). https://doi.org/10.1007/s10517-021-05350-w

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-021-05350-w

Key Words

Navigation